Compare First Trust NASDAQ Cybersecurity ETF (CIBR) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
First Trust NASDAQ Cybersecurity ETF vs GeneDx Holdings Corp — how do they compare? First Trust NASDAQ Cybersecurity ETF trades at $99.84, while GeneDx Holdings Corp trades at $82.39 (market cap $2.44B). The key difference: First Trust NASDAQ Cybersecurity ETF is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| CIBR | WGS | |
|---|---|---|
52-Week High | $100.60 | $167.51 |
52-Week Low | $60.74 | $34.51 |
Market Cap | — | $2.44B |
Sector | — | Technology |
Enterprise Value | — | $2.48B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CIBR trades at $99.87, down 0.73% today, with a bullish technical signal from moving averages but overbought RSI readings. The ETF has outperformed the S&P 500 year-to-date, driven by strong cybersecurity spending trends exceeding $300 billion in 2026. Recent news highlights institutional activity, including Bank of America reducing its stake while First Trust Advisors increased its position.
The outlook remains positive due to secular growth in cybersecurity demand, though high RSI levels suggest near-term consolidation risk. Key opportunities include AI-driven security expansion, while risks involve sector concentration and market volatility. Analyst sentiment is generally bullish, with upgrades citing reasonable valuations and strong momentum.
GeneDx Holdings Corp (WGS) trades at $82.36, up 5.75% in 24 hours, with a bullish technical signal and strong analyst support. Recent Q2 2026 results beat expectations with $0.01 EPS and record testing volumes, though net income margins remain negative. The stock faces class action litigation risks but benefits from institutional buying and new product launches.
Outlook is mixed: bullish technicals and 91% buy ratings suggest upside to the $90 high target, but negative profitability and legal overhangs pose risks. Investors should weigh growth potential against financial sustainability and litigation outcomes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About First Trust NASDAQ Cybersecurity ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index includes securities of companies classified as cyber security companies. The fund is non-diversified.
Read more on CIBR →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
